EcoDrugPlus

Ensembl ID : ENSPNYG00000013275
Gene Symbol: -
Cross references: -
244 Possible Orthologues:

Ensembl ID : ENSPNYG00000019268
Gene Symbol: -
Cross references: -
205 Possible Orthologues:

Ensembl ID : ENSPNYG00000013293
Gene Symbol: -
Cross references: -
244 Possible Orthologues:

Ensembl ID : ENSPNYG00000006508
Gene Symbol: -
Cross references: -
139 Possible Orthologues:

Ensembl ID : ENSPNYG00000008847
Gene Symbol: -
Cross references: -
82 Possible Orthologues:

Ensembl ID : ENSPNYG00000022971
Gene Symbol: -
Cross references: -
183 Possible Orthologues:

Ensembl ID : ENSPNYG00000016261
Gene Symbol: -
Cross references: -
250 Possible Orthologues:

Ensembl ID : ENSPNYG00000017866
Gene Symbol: -
Cross references: -
233 Possible Orthologues:

Ensembl ID : ENSPNYG00000008916
Gene Symbol: -
Cross references: -
11 Possible Orthologues:

Ensembl ID : ENSPNYG00000020626
Gene Symbol: -
Cross references: -
540 Possible Orthologues:

Ensembl ID : ENSPNYG00000016259
Gene Symbol: -
Cross references: -
39 Possible Orthologues:

Ensembl ID : ENSPNYG00000008894
Gene Symbol: -
Cross references: -
145 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).